Your session is about to expire
← Back to Search
Epidural Bupivacaine for Labor Pain
Study Summary
This trial found that the ED90 of bupivacaine via the epidural technique is 3.65 milligrams in women undergoing labor after receiving a lidocaine test dose.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant with one baby, and the baby is positioned head-down and expected to be born between 37 and 42 weeks.You have severe pain when asking for epidural pain relief during labor.I want to have an epidural for pain relief during labor.I have a condition that might require a cesarean delivery, but I'm eligible for a trial of labor after cesarean.You have had a bad reaction to a certain type of numbing medicine before.There are signs that the baby may have health problems before birth.Your cervix is not dilated more than 5 centimeters.I cannot have an epidural due to health reasons.I am pregnant and do not have any major health issues.I have or had a serious health condition, including pregnancy-related issues.
- Group 1: Dural Puncture Epidural Technique
- Group 2: Epidural Technique
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any more openings available for participation in this clinical research?
"As per clinicaltrials.gov, the trial that was initially posted on October 1st 2022 is no longer looking to recruit patients at this time. However, there are 133 other trials open for patient enrollment presently."
Is Bupivacaine Hydrochloride viable for human use without any detrimental side effects?
"Bupivacaine Hydrochloride has been approved, undeniably establishing its safety and thus receiving a score of 3."
Might I be eligible to participate in this experiment?
"This trial is open to 120 individuals aged 18-50 who suffer from anodynia. In addition, singleton mothers with vertex pregnancies between 37 and 42 weeks of gestation that lack major comorbidities, have a dilation below 5 cm and are seeking epidural labor analgesia must display a numerical rating scale (NRS) score greater or equal to five on the 0-10 pain intensity scale at request time."
Is the age limit for trial participants higher than fifty-five?
"This study is only suitable for participants aged between 18 and 50, in accordance with the inclusion criteria."
Share this study with friends
Copy Link
Messenger